Login Register Cart 0
Generic placeholder image

Protein & Peptide Letters

Editor-in-Chief

ISSN (Print): 0929-8665
ISSN (Online): 1875-5305

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

N-Terminal Pro-C-Type Natriuretic Peptide: The Novel Marker in Selected Disease Units

Author(s): Ryszard Tomasiuk*

Volume 29, Issue 2, 2022

Published on: 15 February, 2022

Page: [125 - 132] Pages: 8

DOI: 10.2174/0929866528666211125104944

Price: $65

Abstract

Amino-terminal pro-C-type natriuretic peptide (NT-proCNP) is the N-terminal fragment of the CNP precursor. NT-proCNP occurs in an equimolar concentration with CNP in human plasma and is considered to be a marker of the extent of CNP biosynthesis. A recent study has shown associations between plasma NT-proCNP and blood pressure; it is also an independent predictor of death and cardiac readmission in people with unstable angina. Beyond that, recent studies have focused on the applicability of assessing NT-proCNP peptide levels in the diagnosis of diseases with different etiologies but the same denominator, i.e., inflammation.

This study reviewed recent results on the usability of NT-proCNP peptide levels in the diagnosis of diseases accompanied by statistical analysis of previously reported results.

The data obtained confirmed the applicability of the assessment of NT-proCNP levels in biological fluids in diseases, such as Parkinson's disease, sepsis, meningitis, and asthenozoospermia.

The reported results demonstrated that NT-proCNP is helpful in a variety of diseases. Furthermore, changes in serum or CSF levels of NT-proCNP reflect only inflammatory states related to general inflammation. Local inflammation does not trigger an increase in NT-proCNP level.

Keywords: NT-proCNP, Parkinson's disease, sepsis, meningitis, asthenozoospermia, marker.

« Previous Next »
Graphical Abstract

[1]
Thompson, M.R.; Kaminski, J.J.; Kurt-Jones, E.A.; Fitzgerald, K.A. Pattern recognition receptors and the innate immune response to viral infection. Viruses, 2011, 3(6), 920-940.
[http://dx.doi.org/10.3390/v3060920] [PMID: 21994762]
[2]
Amarante-Mendes, G.P.; Adjemian, S.; Branco, L.M.; Zanetti, L.C.; Weinlich, R.; Bortoluci, K.R. Pattern recognition receptors and the host cell death molecular machinery. Front. Immunol., 2018, 9(2379), 2379.
[http://dx.doi.org/10.3389/fimmu.2018.02379] [PMID: 30459758]
[3]
Rock, K.L.; Kono, H. The inflammatory response to cell death. Annu. Rev. Pathol., 2008, 3, 99-126.
[http://dx.doi.org/10.1146/annurev.pathmechdis.3.121806.151456] [PMID: 18039143]
[4]
Rieckmann, P.; D’Alessandro, F.; Nordan, R.P.; Fauci, A.S.; Kehrl, J.H. IL-6 and tumor necrosis factor-alpha. Autocrine and paracrine cytokines involved in B cell function. J. Immunol., 1991, 146(10), 3462-3468.
[PMID: 2026875]
[5]
Jain, S.; Gautam, V.; Naseem, S. Acute-phase proteins: As diagnostic tool. J. Pharm. Bioallied Sci., 2011, 3(1), 118-127.
[http://dx.doi.org/10.4103/0975-7406.76489] [PMID: 21430962]
[6]
Liu, C.H.; Abrams, N.D.; Carrick, D.M.; Chander, P.; Dwyer, J.; Hamlet, M.R.J.; Macchiarini, F.; PrabhuDas, M.; Shen, G.L.; Tandon, P.; Vedamony, M.M. Biomarkers of chronic inflammation in disease development and prevention: Challenges and opportunities. Nat. Immunol., 2017, 18(11), 1175-1180.
[http://dx.doi.org/10.1038/ni.3828] [PMID: 29044245]
[7]
Ansar, W.; Ghosh, S. Inflammation and inflammatory diseases, markers, and mediators: Role of CRP in some inflammatory diseases. In: Biology of C Reactive Protein in Health and Disease; Springer India: New Delhi, 2016; pp. 67-107.
[8]
Monastero, R.N.; Pentyala, S. Cytokines as biomarkers and their respective clinical cutoff levels. Int. J. Inflamm., 2017, 2017, 4309485-4309485.
[http://dx.doi.org/10.1155/2017/4309485] [PMID: 28487810]
[9]
Johnson, B.D.; Kip, K.E.; Marroquin, O.C.; Ridker, P.M.; Kelsey, S.F.; Shaw, L.J.; Pepine, C.J.; Sharaf, B.; Bairey Merz, C.N.; Sopko, G.; Olson, M.B.; Reis, S.E. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: The National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation (WISE). Circulation, 2004, 109(6), 726-732.
[http://dx.doi.org/10.1161/01.CIR.0000115516.54550.B1] [PMID: 14970107]
[10]
Kappelmayer, J.; Nagy, B., Jr; Miszti-Blasius, K.; Hevessy, Z.; Setiadi, H. The emerging value of P-selectin as a disease marker. Clin. Chem. Lab. Med., 2004, 42(5), 475-486.
[http://dx.doi.org/10.1515/CCLM.2004.082] [PMID: 15202782]
[11]
Loria, V.; Dato, I.; Graziani, F.; Biasucci, L.M. Myeloperoxidase: A new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediators Inflamm., 2008, 2008, 135625-135625.
[http://dx.doi.org/10.1155/2008/135625] [PMID: 18382609]
[12]
Dogan, A.; Tuzun, N.; Turker, Y.; Akcay, S.; Kaya, S.; Ozaydin, M. Matrix metalloproteinases and inflammatory markers in coronary artery ectasia: Their relationship to severity of coronary artery ectasia. Coron. Artery Dis., 2008, 19(8), 559-563.
[http://dx.doi.org/10.1097/MCA.0b013e3283109079] [PMID: 19005290]
[13]
Best, P.J.M.; Gersh, B.J. Cell adhesion molecules and inflammation in acute coronary syndromes: Markers and emerging risk factors. Eur. Heart J., 2001, 22(14), 1155-1159.
[http://dx.doi.org/10.1053/euhj.2001.2661] [PMID: 11440488]
[14]
Lenderink, T.; Heeschen, C.; Fichtlscherer, S.; Dimmeler, S.; Hamm, C.W.; Zeiher, A.M.; Simoons, M.L.; Boersma, E. Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes. J. Am. Coll. Cardiol., 2006, 47(2), 307-311.
[http://dx.doi.org/10.1016/j.jacc.2005.08.063] [PMID: 16412852]
[15]
Madjid, M.; Ali, M.; Willerson, J.T. Lipoprotein-associated phospholipase A2 as a novel risk marker for cardiovascular disease: A systematic review of the literature. Tex. Heart Inst. J., 2010, 37(1), 25-39.
[PMID: 20200624]
[16]
Lippert, S.; Goetze, J.P. C-type natriuretic-derived peptides as biomarkers in human disease. Biomarkers Med., 2010, 4(4), 631-639.
[http://dx.doi.org/10.2217/bmm.10.67] [PMID: 20701450]
[17]
Matsuo, A.; Nagai-Okatani, C.; Nishigori, M.; Kangawa, K.; Minamino, N. Natriuretic peptides in human heart: Novel insight into their molecular forms, functions, and diagnostic use. Peptides, 2019, 111, 3-17.
[http://dx.doi.org/10.1016/j.peptides.2018.08.006] [PMID: 30120963]
[18]
Lok, D.J.; Klip, I.T.; Voors, A.A.; Lok, S.I.; Bruggink-André de la Porte, P.W.; Hillege, H.L.; Jaarsma, T.; van Veldhuisen, D.J.; van der Meer, P. Prognostic value of N-terminal pro C-type natriuretic peptide in heart failure patients with preserved and reduced ejection fraction. Eur. J. Heart Fail., 2014, 16(9), 958-966.
[http://dx.doi.org/10.1002/ejhf.140] [PMID: 25082741]
[19]
Kaiser, R.; Grotemeyer, K.; Lepper, P.; Stokes, C.; Bals, R.; Wilkens, H. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension. Respir. Med., 2015, 109(9), 1213-1223.
[http://dx.doi.org/10.1016/j.rmed.2015.02.014] [PMID: 26194624]
[20]
Cappellin, E.; Gatti, R.; Antonelli, G.; Soldà, G.; Ragazzi, E.; De Palo, E.F.; Spinella, P. Natriuretic peptide fragments as possible biochemical markers of hypertension in the elderly. J. Cardiovasc. Med. (Hagerstown), 2013, 14(4), 308-313.
[http://dx.doi.org/10.2459/JCM.0b013e3283536517] [PMID: 22498997]
[21]
Vlachopoulos, C.; Ioakeimidis, N.; Terentes-Printzios, D.; Aznaouridis, K.; Baou, K.; Bratsas, A.; Lazaros, G.; Stefanadis, C. Amino-terminal pro-C-type natriuretic peptide is associated with arterial stiffness, endothelial function and early atherosclerosis. Atherosclerosis, 2010, 211(2), 649-655.
[http://dx.doi.org/10.1016/j.atherosclerosis.2010.03.020] [PMID: 20399429]
[22]
Prickett, T.C.R.; Doughty, R.N.; Troughton, R.W.; Frampton, C.M.; Whalley, G.A.; Ellis, C.J.; Espiner, E.A.; Richards, A.M. C-type natriuretic peptides in coronary disease. Clin. Chem., 2017, 63(1), 316-324.
[http://dx.doi.org/10.1373/clinchem.2016.257816] [PMID: 28062626]
[23]
Keng, B.M.H.; Gao, F.; Tan, R.S.; Ewe, S.H.; Teo, L.L.Y.; Xie, B.Q.; Goh, G.B.B.; Koh, W-P.; Koh, A.S. N-Terminal pro C-Type Natriuretic Peptide (NTproCNP) and myocardial function in ageing. PLoS One, 2018, 13(12), e0209517.
[http://dx.doi.org/10.1371/journal.pone.0209517] [PMID: 30566484]
[24]
Prickett, T.C.R.; Darlow, B.A.; Troughton, R.W.; Cameron, V.A.; Elliott, J.M.; Martin, J.; Horwood, L.J.; Espiner, E.A. New insights into cardiac and vascular natriuretic peptides: Findings from young adults born with very low birth weight. Clin. Chem., 2018, 64(2), 363-373.
[http://dx.doi.org/10.1373/clinchem.2017.280354] [PMID: 29097512]
[25]
Schouten, B.J.; Prickett, T.C.; Hunt, P.J.; Richards, A.M.; Geffner, M.E.; Olney, R.C.; Espiner, E.A. C-type natriuretic peptide forms in adult hyperthyroidism: correlation with thyroid hormones and markers of bone turnover. Clin. Endocrinol. (Oxf.), 2012, 76(6), 790-796.
[http://dx.doi.org/10.1111/j.1365-2265.2011.04295.x] [PMID: 22103885]
[26]
Mylin, A.K.; Goetze, J.P.; Heickendorff, L.; Ahlberg, L.; Dahl, I.M.; Abildgaard, N.; Gimsing, P. N-terminal pro-C-type natriuretic peptide in serum associated with bone destruction in patients with multiple myeloma. Biomarkers Med., 2015, 9(7), 679-689.
[http://dx.doi.org/10.2217/bmm.15.35] [PMID: 26174842]
[27]
Akseki Temür, H.; Vardar, S.A.; Demir, M.; Palabıyık, O.; Karaca, A.; Guksu, Z.; Ortanca, A.; Süt, N. The alteration of NTproCNP plasma levels following anaerobic exercise in physically active young men. Anatol. J. Cardiol., 2015, 15(2), 97-102.
[http://dx.doi.org/10.5152/akd.2014.5204] [PMID: 25252292]
[28]
Wasko, M.K.; Bobecka-Wesołowska, K.; Tomasiuk, R.; Kowalczewski, J. Measurement of the inflammatory response in the early postoperative period after hip and knee arthroplasty. Clin. Chem. Lab. Med., 2015, 53(11), 1785-1792.
[http://dx.doi.org/10.1515/cclm-2014-1055] [PMID: 25781692]
[29]
Tomasiuk, R.; Faundez, R.; Cacko, M.; Mikaszewska-Sokolewicz, M.; Cacko, A.; Rabijewski, M. NT-proCNP as a new indicator of asthenozoospermia. Adv. Med. Sci., 2017, 62(1), 74-77.
[http://dx.doi.org/10.1016/j.advms.2016.04.002] [PMID: 28189122]
[30]
Koziorowski, D.; Tomasiuk, R.; Szlufik, S.; Friedman, A. Inflammatory cytokines and NT-proCNP in Parkinson’s disease patients. Cytokine, 2012, 60(3), 762-766.
[http://dx.doi.org/10.1016/j.cyto.2012.07.030] [PMID: 22910321]
[31]
Espiner, E.A.; Dalrymple-Alford, J.C.; Prickett, T.C.; Alamri, Y.; Anderson, T.J. C-type natriuretic peptide in Parkinson's disease: Reduced secretion and response to deprenyl. J. Neural Trans. (Vienna, Austria : 1996), 2014, 121(4), 371-378.
[32]
Woodward, Z.; Prickett, T.C.R.; Espiner, E.A.; Anderson, T.J. Central and systemic C-type natriuretic peptide are both reduced in Parkinson’s disease. Parkinsonism Relat. Disord., 2017, 43, 15-19.
[http://dx.doi.org/10.1016/j.parkreldis.2017.06.019] [PMID: 28673612]
[33]
Tomasiuk, R.; Mikaszewska-Sokolewicz, M.; Szlufik, S.; Rzepecki, P.; Lazowski, T. The prognostic value of concomitant assessment of NT-proCNP, C-reactive protein, procalcitonin and inflammatory cytokines in septic patients. Crit. Care, 2014, 18(3), 440.
[http://dx.doi.org/10.1186/cc13944] [PMID: 25043511]
[34]
Efron, B. The bootstrap and modern statistics. J. Am. Stat. Assoc., 2000, 95(452), 1293-1296.
[http://dx.doi.org/10.1080/01621459.2000.10474333]
[35]
Aickin, M.; Gensler, H. Adjusting for multiple testing when reporting research results: the Bonferroni vs. Holm methods. Am. J. Public Health, 1996, 86(5), 726-728.
[http://dx.doi.org/10.2105/AJPH.86.5.726] [PMID: 8629727]
[36]
Thompson, J.D.; Higgins, D.G.; Gibson, T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res., 1994, 22(22), 4673-4680.
[http://dx.doi.org/10.1093/nar/22.22.4673] [PMID: 7984417]
[37]
de Bold, A.J.; Borenstein, H.B.; Veress, A.T.; Sonnenberg, H. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats. Life Sci., 1981, 28(1), 89-94.
[http://dx.doi.org/10.1016/0024-3205(81)90370-2] [PMID: 7219045]
[38]
Sudoh, T.; Minamino, N.; Kangawa, K.; Matsuo, H. Brain natriuretic peptide-32: N-terminal six amino acid extended form of brain natriuretic peptide identified in porcine brain. Biochem. Biophys. Res. Commun., 1988, 155(2), 726-732.
[http://dx.doi.org/10.1016/S0006-291X(88)80555-2] [PMID: 3421965]
[39]
Sudoh, T.; Minamino, N.; Kangawa, K.; Matsuo, H. C-type natriuretic peptide (CNP): A new member of natriuretic peptide family identified in porcine brain. Biochem. Biophys. Res. Commun., 1990, 168(2), 863-870.
[http://dx.doi.org/10.1016/0006-291X(90)92401-K] [PMID: 2139780]
[40]
Wu, C.; Wu, F.; Pan, J.; Morser, J.; Wu, Q. Furin-mediated processing of Pro-C-type natriuretic peptide. J. Biol. Chem., 2003, 278(28), 25847-25852.
[http://dx.doi.org/10.1074/jbc.M301223200] [PMID: 12736257]
[41]
Sangaralingham, S.J.; Heublein, D.M.; Grande, J.P.; Cataliotti, A.; Rule, A.D.; McKie, P.M.; Martin, F.L.; Burnett, J.C., Jr Urinary C-type natriuretic peptide excretion: A potential novel biomarker for renal fibrosis during aging. Am. J. Physiol. Renal Physiol., 2011, 301(5), F943-F952.
[http://dx.doi.org/10.1152/ajprenal.00170.2011] [PMID: 21865266]
[42]
Stingo, A.J.; Clavell, A.L.; Heublein, D.M.; Wei, C.M.; Pittelkow, M.R.; Burnett, J.C., Jr Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am. J. Physiol., 1992, 263(4 Pt 2), H1318-H1321.
[PMID: 1384363]
[43]
Totsune, K.; Takahashi, K.; Ohneda, M.; Itoi, K.; Murakami, O.; Mouri, T. C-type natriuretic peptide in the human central nervous system: Distribution and molecular form. Peptides, 1994, 15(1), 37-40.
[http://dx.doi.org/10.1016/0196-9781(94)90167-8] [PMID: 8015979]
[44]
Hagiwara, H.; Sakaguchi, H.; Itakura, M.; Yoshimoto, T.; Furuya, M.; Tanaka, S.; Hirose, S. Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J. Biol. Chem., 1994, 269(14), 10729-10733.
[http://dx.doi.org/10.1016/S0021-9258(17)34119-4] [PMID: 7908295]
[45]
Kalra, P.R.; Clague, J.R.; Bolger, A.P.; Anker, S.D.; Poole-Wilson, P.A.; Struthers, A.D.; Coats, A.J. Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation, 2003, 107(4), 571-573.
[http://dx.doi.org/10.1161/01.CIR.0000047280.15244.EB] [PMID: 12566368]
[46]
Olney, R.C.; Permuy, J.W.; Prickett, T.C.R.; Han, J.C.; Espiner, E.A. Amino-terminal propeptide of C-type natriuretic peptide (NTproCNP) predicts height velocity in healthy children. Clin. Endocrinol. (Oxf.), 2012, 77(3), 416-422.
[http://dx.doi.org/10.1111/j.1365-2265.2012.04392.x] [PMID: 22435455]
[47]
Scherzer, C.R.; Eklund, A.C.; Morse, L.J.; Liao, Z.; Locascio, J.J.; Fefer, D.; Schwarzschild, M.A.; Schlossmacher, M.G.; Hauser, M.A.; Vance, J.M.; Sudarsky, L.R.; Standaert, D.G.; Growdon, J.H.; Jensen, R.V.; Gullans, S.R. Molecular markers of early Parkinson’s disease based on gene expression in blood. Proc. Natl. Acad. Sci. USA, 2007, 104(3), 955-960.
[http://dx.doi.org/10.1073/pnas.0610204104] [PMID: 17215369]
[48]
Stefanis, L. α-Synuclein in Parkinson’s disease. Cold Spring Harb. Perspect. Med., 2012, 2(2), a009399-a009399.
[http://dx.doi.org/10.1101/cshperspect.a009399] [PMID: 22355802]
[49]
Singh, A.P.; Ramana, G.; Bajaj, T.; Singh, V.; Dwivedi, S.; Behari, M.; Dey, A.B.; Dey, S. Elevated Serum SIRT 2 may differentiate Parkinson’s disease from Atypical Parkinsonian syndromes. Front. Mol. Neurosci., 2019, 12(129), 129.
[http://dx.doi.org/10.3389/fnmol.2019.00129] [PMID: 31244600]
[50]
Dufek, M.; Hamanová, M.; Lokaj, J.; Goldemund, D.; Rektorová, I.; Michálková, Z.; Sheardová, K.; Rektor, I. Serum inflammatory biomarkers in Parkinson’s disease. Parkinsonism Relat. Disord., 2009, 15(4), 318-320.
[http://dx.doi.org/10.1016/j.parkreldis.2008.05.014] [PMID: 18672391]
[51]
Bahrami, S.; Pelinka, L.; Khadem, A.; Maitzen, S.; Hawa, G.; van Griensven, M.; Redl, H. Circulating NT-proCNP predicts sepsis in multiple-traumatized patients without traumatic brain injury. Crit. Care Med., 2010, 38(1), 161-166.
[http://dx.doi.org/10.1097/CCM.0b013e3181b78a06] [PMID: 19730251]
[52]
Koch, A.; Voigt, S.; Sanson, E.; Dückers, H.; Horn, A.; Zimmermann, H.W.; Trautwein, C.; Tacke, F. Prognostic value of circulating amino-terminal pro-C-type natriuretic peptide in critically ill patients. Crit. Care, 2011, 15(1), R45-R45.
[http://dx.doi.org/10.1186/cc10007] [PMID: 21281508]
[53]
Sharma, A. Male infertility; Evidences, risk factors, causes, diagnosis and management in human. Ann. Clin. Laboratory Res., 2017, 05, 188.
[54]
Rehman, R.; Zahid, N.; Amjad, S.; Baig, M.; Gazzaz, Z.J. Relationship between smoking habit and sperm parameters among patients attending an infertility clinic. Front. Physiol., 2019, 10(1356), 1356.
[http://dx.doi.org/10.3389/fphys.2019.01356] [PMID: 31736779]
[55]
Donnelly, G.P.; McClure, N.; Kennedy, M.S.; Lewis, S.E. Direct effect of alcohol on the motility and morphology of human spermatozoa. Andrologia, 1999, 31(1), 43-47.
[http://dx.doi.org/10.1111/j.1439-0272.1999.tb02841.x] [PMID: 9949888]
[56]
Agarwal, A.; Rana, M.; Qiu, E.; AlBunni, H.; Bui, A.D.; Henkel, R. Role of oxidative stress, infection and inflammation in male infertility. Andrologia, 2018, 50(11), e13126.
[http://dx.doi.org/10.1111/and.13126] [PMID: 30569652]
[57]
Mahmoud, A.M.; Geslevich, J.; Kint, J.; Depuydt, C.; Huysse, L.; Zalata, A.; Comhaire, F.H. Seminal plasma alpha-glucosidase activity and male infertility. Hum. Reprod., 1998, 13(3), 591-595.
[http://dx.doi.org/10.1093/humrep/13.3.591] [PMID: 9572418]
[58]
Gauntner, T.D.; Prins, G.S. Prostate-cell biology and secretion. Encyclopedia of Reproduction, 2nd ed.; Skinner, M.K., Ed.; Academic Press: Oxford, 2018, pp. 325-333.
[http://dx.doi.org/10.1016/B978-0-12-801238-3.64372-6]
[59]
Fallah, A.; Mohammad-Hasani, A.; Colagar, A.H. Zinc is an essential element for male fertility: A review of Zn roles in men’s health, germination, sperm quality, and fertilization. J. Reprod. Infertil., 2018, 19(2), 69-81.
[PMID: 30009140]
[60]
Andrade-Rocha, F.T. Seminal fructose levels in male infertility: Relationship with sperm characteristics. Int. Urol. Nephrol., 1999, 31(1), 107-111.
[http://dx.doi.org/10.1023/A:1007136209970] [PMID: 10408311]
[61]
Feng, R-X.; Lu, J-C.; Zhang, H-Y.; Lü, N-Q. A Pilot Comparative Study of 26 biochemical markers in seminal plasma and serum in infertile men. BioMed Res. Int., 2015, 2015, 805328.
[http://dx.doi.org/10.1155/2015/805328] [PMID: 26539526]
[62]
Hussain, T.; Tan, B.; Yin, Y.; Blachier, F.; Tossou, M.C.B.; Rahu, N. Oxidative stress and inflammation: What polyphenols can do for us? Oxid. Med. Cell. Longev., 2016, 2016, 7432797.
[http://dx.doi.org/10.1155/2016/7432797] [PMID: 27738491]
[63]
Lippert, S.K.; Rehfeld, J.F.; Goetze, J.P. Processing-independent analysis for pro-C-type natriuretic peptide. J. Immunol. Methods, 2010, 362(1-2), 32-37.
[http://dx.doi.org/10.1016/j.jim.2010.08.003] [PMID: 20797397]
[64]
Xia, H.; Chen, Y.; Wu, K.J.; Zhao, H.; Xiong, C.L.; Huang, D.H. Role of C-type natriuretic peptide in the function of normal human sperm. Asian J. Androl., 2016, 18(1), 80-84.
[http://dx.doi.org/10.4103/1008-682X.150254] [PMID: 25926602]
[65]
Logan, S.A.E.; MacMahon, E. Viral meningitis. BMJ, 2008, 336(7634), 36-40.
[http://dx.doi.org/10.1136/bmj.39409.673657.AE] [PMID: 18174598]
[66]
Read, S.J.; Kurtz, J.B. Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR screening assay. J. Clin. Microbiol., 1999, 37(5), 1352-1355.
[http://dx.doi.org/10.1128/JCM.37.5.1352-1355.1999] [PMID: 10203485]
[67]
Kanoh, Y.; Ohara, T.; Akahoshi, T. Acute inflammatory biomarkers in cerebrospinal fluid as indicators of blood cerebrospinal fluid barrier damage in Japanese subjects with infectious meningitis. Clin. Lab., 2011, 57(1-2), 37-46.
[PMID: 21391463]
[68]
Tomasiuk, R.; Lipowski, D.; Szlufik, S.; Peplinska, K.; Mikaszewska-Sokolewicz, M. Higher level of NT-proCNP in cerebrospinal fluid of patients with meningitis. Neurosci. Lett., 2016, 614, 29-32.
[http://dx.doi.org/10.1016/j.neulet.2015.12.053] [PMID: 26742639]
[69]
Levy, M.M.; Fink, M.P.; Marshall, J.C.; Abraham, E.; Angus, D.; Cook, D.; Cohen, J.; Opal, S.M.; Vincent, J.L.; Ramsay, G. 2001 SCCM/ESICM/ACCP/ATS/SIS international sepsis definitions conference. Crit. Care Med., 2003, 31(4), 1250-1256.
[http://dx.doi.org/10.1097/01.CCM.0000050454.01978.3B] [PMID: 12682500]
[70]
Singer, M.; Deutschman, C.S.; Seymour, C.W.; Shankar-Hari, M.; Annane, D.; Bauer, M.; Bellomo, R.; Bernard, G.R.; Chiche, J-D.; Coopersmith, C.M.; Hotchkiss, R.S.; Levy, M.M.; Marshall, J.C.; Martin, G.S.; Opal, S.M.; Rubenfeld, G.D.; van der Poll, T.; Vincent, J-L.; Angus, D.C. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, 2016, 315(8), 801-810.
[http://dx.doi.org/10.1001/jama.2016.0287] [PMID: 26903338]
[71]
Jin, M.; Khan, A.I. Procalcitonin: Uses in the clinical laboratory for the diagnosis of sepsis. Lab. Med., 2010, 41(3), 173-177.
[http://dx.doi.org/10.1309/LMQ2GRR4QLFKHCH9]
[72]
Gabay, C.; Kushner, I. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med., 1999, 340(6), 448-454.
[http://dx.doi.org/10.1056/NEJM199902113400607] [PMID: 9971870]
[73]
Faix, J.D. Biomarkers of sepsis. Crit. Rev. Clin. Lab. Sci., 2013, 50(1), 23-36.
[http://dx.doi.org/10.3109/10408363.2013.764490] [PMID: 23480440]
[74]
Linder, A.; Christensson, B.; Herwald, H.; Björck, L.; Akesson, P. Heparin-binding protein: An early marker of circulatory failure in sepsis. Clin. Infect. Dis., 2009, 49(7), 1044-1050.
[http://dx.doi.org/10.1086/605563] [PMID: 19725785]
[75]
Gouel-Chéron, A.; Dupin, M.; Chanteperdix, M.; Chaillol, I.; Venet, F.; Pachot, A.; Monneret, G.; Floccard, B.; Allaouchiche, B. Concomitant assessment of PSP and NT-proCNP as predictive markers of sepsis in severe trauma patients under mechanical ventilation. Crit. Care, 2013, 17(3), 434.
[http://dx.doi.org/10.1186/cc12702] [PMID: 23701994]

Rights & Permissions Print Cite
Article Metrics
18
1
© 2024 Bentham Science Publishers | Privacy Policy